Flow Imaging Microscopy combined with Light Obscuration Capabilities
- Response deadline
- Sep 4, 2026 Closed
- Date posted
- Aug 28, 2026
- Source
- Open notice
Description
The purpose of Admendment 0001 is to update the SOW and Terms and conditions to include Option years for the service agreement. ________________________________________________________________________________ The purpose of Amendment 0001 is as follows: 1. Extend due date for offers to September 4, 2026.; 2. Revised Title to read "flow imaging instrument combined with light obscuration capabilities" 3. Provide updated Statement of Work and Attachment 2 - Terms and Conditions to include Option Periods for Service Agreement _________________________________________________________________________________________________________ The Bioprocess Measurements Group at the National Institute of Standards and Technology (NIST) located at Gaithersburg, MD provides measurement science and standards for robust characterization of biologically or synthetically derived particles that are relevant in the biomanufacturing industry. These particle types can be hard to distinguish, and regulatory guidelines require detailed characterization of these particles in drug products. Industry currently relies heavily on flow imaging microscopy and light obscuration (compendial method) for characterizing these particles in their products. We are requesting an updated flow imaging instrument with light obscuration capabilities to replace two outdated, unsupported systems (Flow imaging and Light Obscuration) which no longer reflect instruments used in industry which limits data comparability and collaboration.
Classifications
Documents (8)
- Solicitation_1333ND26QNB640309.docx.docx45 KBNot yet available
- Updated 8-28-26 Final SOW_Flow Imaging Microscopy.docx.docx38 KBNot yet available
- Final_SOW_measurement tool REV1.docx.docx37 KBNot yet available
- Updated 8-28-26 Final Solicitation_1333ND26QNB640309 flow imaging microscopy.docx.docx45 KBNot yet available
- Attachment 2- Applicable Provisions and Clauses.docx.docx52 KBNot yet available
- Revised Final_SOW_measurement tool.docx.docx37 KBNot yet available
- Updated 8-28-26 Revised Attachment 2- Applicable Provisions and Clauses.docx.docx55 KBNot yet available
- Revised Attachment 2- Applicable Provisions and Clauses.docx.docx55 KBNot yet available
Contacts
- robert.singman@nist.gov3019756388
- rene.edwards@nist.gov3019756107
Similar contracts
- NX EQ Image Guided Surgical Navigation SystemDue Nov 5, 2026
- Electro-Therapeutic Modalities for Pain Management (ETMPM) - Transcutaneous Electrical Nerve Stimulation (TENS) Procurement ProgramColoradoDue Oct 30, 2026
- Premier Shockwave Notice of IntentTexasDue Oct 28, 2026
- Audiological Diagnostic Testing EquipmentCaliforniaDue Oct 21, 2026
- Shockwave Therapy UnitDue Oct 20, 2026
- 691 - Emergency - Seismiq Intravascular Lithotripsy Console